MSN Laboratories is one of the fastest-growing, research based, and fully integrated pharmaceutical companies worldwide, with its headquarters in Hyderabad, India. Founded by CMD Dr. MSN Reddy in 2003, MSN Labs' mission has been to make high-quality medicines affordable and accessible worldwide.

The organization currently boasts 25 state-of-the-art manufacturing facilities (17 for API and 8 for finished dosages) alongside Asia’s Largest Integrated R&D Centre, spanning across India and the USA. 

The group’s integrated R&D Centre enables research in both API and Finished Dosages under one roof, empowering the organization to swiftly introduce new and cost-effective therapies in global markets. Supported by a dedicated team of over 20,000 experienced professionals, the organization has gained global recognition for its innovation, quality, and swift delivery.

MSN Labs maintains robust regulatory protocols and streamlined approval processes, ensuring that our pharmaceutical products meet international benchmarks. This has positioned us as a trusted global provider of pharmaceuticals, earning accreditations from reputable organizations such as USFDA, WHO, KSFDA, EDQM, PMDA Japan, and Health Canada. Our commitment to enhancing the regulatory framework promises that the medicines manufactured at our state-of-the-art facilities meet the highest standards of safety, efficacy, and quality.